VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
VM Oncology, LLC
Incyte Corporation
Merck Sharp & Dohme LLC
Incyte Corporation
A2 Biotherapeutics Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Sotio Biotech Inc.
Travera Inc
Kyowa Kirin Co., Ltd.
Xencor, Inc.
Incyte Corporation
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
Incyte Corporation
Novartis
Pierian Biosciences
INSYS Therapeutics Inc
GlaxoSmithKline